Human angiotensin-converting enzyme I/D and α-actinin 3 R577X genotypes and muscle functional and contractile properties

Experimental Physiology

Volumn 94, Issue 1, 2009, Pages 81-89

  McCauley, Tracey ^a   Mastana, Sarabjit S ^a   Hossack, James ^a   MacDonald, Martin ^a   Folland, Jonathan P ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 3; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; MUSCLE STRENGTH; MUSCLE TWITCH; NORMAL HUMAN; PROTEIN BLOOD LEVEL;

EID: 58149105438     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2008.043075     Document Type: Article

References (42)

1. Akhmetov II, Astratenkova IV, Druzhevskaia AM, Komkova AI, Liubaeva EV, Tarakin PP, Shenkman BS & Rogozkin VA (2006). The association of gene polymorphisms with the muscle fibre type composition [in Russian]. Ross Fiziol Zh Im I M Sechenova 92, 883 888.
2. Blanchard A, Ohanian V & Critchley D (1989). The structure and function of α-actinin. J Muscle Res Cell Motil 10, 280 289.
3. Brown NJ, Blais C Jr., Gandhi S & Adam A (1998). ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 32, 373 377.
4. Charbonneau DE, Hanson ED, Ludlow AT, Delmonico MJ, Hurley BF & Roth SM (2008). ACE genotype and the muscle hypertrophic responses to strength training. Med Sci Sports Exerc 40, 677 683.
5. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, Price TB, Angelopoulos TJ, Gordon PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, Seip RL & Hoffman EP (2005). ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 99, 154 163.
6. Delmonico MJ, Kostek MC, Doldo NA, Hand BD, Walsh S, Conway JM, Carignan CR, Roth SM & Hurley BF (2007). α-Actinin-3 (ACTN3) R577X polymorphism influences knee extensor peak power response to strength training in older men and women. J Am Geraiatr Soc 62, 206 212.
7. Durnin JV & Womersley J (1974). Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32, 77 97.
8. Edwards RH, Young A, Hosking GP & Jones DA (1977). Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 52, 283 290.
9. Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H & Jones D (2000). Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 85, 575 579.
10. Folland JP, Hawker K, Leach B, Little T & Jones DA (2005). Strength training: isometric training at a range of joint angles versus dynamic training. J Sports Sci 23, 817 824.
11. Frederiksen H, Bathum L, Worm C & Chistensen K (2003). ACE genotype and physical training effects: a randomized study among elderly Danes. Aging Clin Exp Res 15, 284 291.
12. Gordon SE, Davis BS, Carlson CJ & Booth FW (2001). ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metabol 280, E150 E159.
13. Gür H, Gransberg L, vanDyke D, Knutsson E & Larsson L (2003). Relationship between in vivo muscle force at different speeds of isokinetic movements and myosin isoform expression in men and women. Eur J Appl Physiol 88, 487 496.
14. Hamada T, Sale DG, MacDougall JD & Tarnopolsky MA (2000). Postactivation potentiation, fiber type, and twitch contraction time in human knee extensor muscles. J Appl Physiol 88, 2131 2137.
15. Hopkinson NS, Nickol AH, Payne J, Hawe E, Man W, Moxham J, Montgomery H & Polkey MI (2004). ACE gene and strength in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 170, 395 399.
16. Ishigai Y, Mori T, Ikeda T, Fukuzawa A & Shibano T (1997). Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes. Am J Physiol Heart Circ Physiol 273, H2659 H2663.
17. Ivy L, Withers RT, Brose G, Maxwell BD & Costill DL (1981). Isokinetic contractile properties of the quadriceps with relation to fibre type. Eur J Appl Physiol Occup Physiol 47, 247 255.
18. Jones P & Parker DF (1989). Development of portable strain gauge to measure human muscle isometric strength. J Physiol 80, 765 772.
19. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH & Pollak MR (2000). Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24, 251 256.
20. MacArthur D & North KN (2007). ACTN3: A genetic influence on muscle function and athletic performance. Exerc Sport Sci Rev 35, 30 34.
21. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, Easteal S & North K (2001). Differential expression of the actin-binding proteins, α-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet 10, 1335 1346.
22. Myerson SG, Hemingway H, Budget R, Martin J, Humphries S & Montogmery H (1999). Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 87, 1313 1316.
23. Nazarov IB, Woods DR, Montgomery HE, Shneider OV, Kazakov VI, Tomilin NV & Rogozkin VA (2001). The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 9, 797 801.
24. Niemi A & Majamaa K (2005). Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 13, 965 969.
25. North KN & Beggs AH (1996). Deficiency of a skeletal muscle isoform of α-actinin-3 in merosin-positive congenital muscular dyrophy. Neuromuscul Disord 6, 229 235.
26. North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S & Beggs AH (1999). A common nonsense mutation results in α-actinin-3 deficiency in the general population. Nat Genet 21, 353 354.
27. Parker DF, Round JM, Sacco P & Jones DA (1990). A cross-sectional survey of upper and lower limb strength in boys and girls during childhood and adolescence. Ann Hum Biol 17, 199 221.
28. Pescatello LS, Kostek MA, Gordish-Dressman H, Thompson PD, Seip RL, Price TB, Angelopoulos TJ, Clarkson PM, Gordon PM, Moyna NM, Visich PS, Zoeller RF, Devaney JM, Hoffman EP (2006). ACE ID genotype and muscle strength and size response to unilateral resistance training. Med Sci Sports Exerc 38, 1074 1081.
29. Rankinen T, Bray MS, Hagberg JM, Perusse L, Roth SM, Wolfarth B & Bouchard C (2006). The human gene map for performance and health-related fitness phenotypes: the 2005 update. Med Sci Sports Exerc 38, 1863 1888.
30. Rigat B, Hubert C, Alhenc-Gelas F, Cambien P, Corvol P & Soubrier F (1990). An insertion/deletion polymorphism in the angiotensin-1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86, 1343 1364.
31. Simoneau JA & Bouchard C (1995). Skeletal muscle metabolism and body fat content in men and women. Obes Res 3, 23 29.
32. Siri WE (1956). The gross composition of the body. Adv Biol Med Phys 4, 239 280.
33. Squire JM (1992). Muscle filament lattices and stretch-activation: the match mismatched model researched. J Muscle Res Cell Motil 13, 183 189.
34. Suter E, Herzog W, Sokolosky J, Wiley JP & Macintosh BR (1993). Muscle fibre type distribution as estimated by Cybex testing and by muscle biopsy. Med Sci Sports Exerc 25, 363 370.
35. Thomis MA, Huygens W, Heuninckx S, Chagnon M, Maes HH, Claessens AL, Vlietinck R, Bouchard C & Beunen GP (2004). Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur J Appl Physiol 92, 267 274.
36. Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leemputte M, Hespel P & Thomis M (2007). The ACTN3 (R577X) genotype is associated with fibre type distribution. Physiol Genomics 32, 58 63.
37. Westerkamp CM & Gordon SE (2005). Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle. Am J Physiol Regul Integr Comp Physiol 289, R1223 R1231.
38. Williams AG, Day SH, Folland JP, Gohlke P, Dhamrait S & Montgomery HE (2005). Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med Sci Sports Exerc 37, 944 948.
39. Williams AG & Folland JP (2008). Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol 586, 113 1231.
40. Woods D, Onambele G, Woledge R, Skelton D, Bruce S, Humphries & Montgomery H (2001). Angiotensin I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J Clin Endocrinol Metab 86, 2200 2204.
41. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S & North K (2003). ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73, 627 631.
42. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M & Saku K (2003). The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibres in human skeletal muscle. Clin Genet 63, 139 144.